Literature DB >> 16185754

Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma.

Gamal H Eltabbakh1, Sharon L Mount.   

Abstract

OBJECTIVE: The purpose of our study was to find if uterine manipulation at the time of laparoscopic hysterectomy among women with endometrial carcinoma increases the incidence of malignant cells in the peritoneal washings.
MATERIAL AND METHODS: We conducted a prospective study including women with clinical stage I endometrioid endometrial carcinoma undergoing laparoscopic surgery between 07/01/2000 and 07/01/2004. Surgery on all patients was conducted by the same surgeon using the same technique and instruments. Two sets of peritoneal washings were obtained, one before and one after the insertion of the Pelosi uterine manipulator. The two sets of washings were blindly reviewed by the same cytopathologist for the presence of malignant cells. Correlation was made between the two sets of washings.
RESULTS: Forty-two consecutive women (age 46-90, median: 58) were enrolled in the study. The procedure was converted to laparotomy in 3 (7.6%) patients after obtaining the two sets of washings. The preoperative tumor grades were: G1: 22 (52.4%), G2: 12 (28.6%), and G3: 8 (19.0). The incidence of positive peritoneal washings was 14.3%. All patients underwent laparoscopically assisted vaginal hysterectomy with bilateral salpingo-oophorectomy, 30 patients had bilateral pelvic lymphadenectomy, and 5 patients had bilateral pelvic and para-aortic lymphadenectomy. There was perfect agreement between the two sets of washings in all patients (100%, P < .001). No patients had positive washings after the insertion of the uterine manipulator if the washings were negative before the insertion. The surgical stages were: IA: 14 (33.3%), IB: 12 (28.6%), IC: 7 (16.7%), IIA: 1 (2.4%), IIB: 1 (2.4%), IIIA: 4 (9.5%), IIIB: 1 (2.4%), IIIC: 1 (2.4%), and IV: 1 (2.4%). Twenty-nine patients received no postoperative treatment, 2 received chemotherapy, 3 received Megace, and 9 received radiation therapy. Patients were followed-up for 7-56 months (median: 28). Two patients had tumor recurrence, and one patient died secondary to her disease. Two other patients died secondary to other causes.
CONCLUSIONS: We conclude that uterine manipulation at the time of laparoscopic hysterectomy does not increase the incidence of positive peritoneal cytology among women with endometrial carcinoma.

Entities:  

Mesh:

Year:  2005        PMID: 16185754     DOI: 10.1016/j.ygyno.2005.08.040

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

1.  Comparison of laparoscopy and laparotomy for management of endometrial carcinoma: a prospective randomized study with 11-year experience.

Authors:  Qi Lu; Haiyan Liu; Chongdong Liu; Shuzhen Wang; Shuhong Li; Shuli Guo; Junli Lu; Zhenyu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-06       Impact factor: 4.553

2.  Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness.

Authors:  Yara Abdel Khalek; Roger Bitar; Costas Christoforou; Simone Garzon; Alessandro Tropea; Antonio Biondi; Zaki Sleiman
Journal:  Updates Surg       Date:  2019-10-12

3.  Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator : Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer.

Authors:  Franziska Siegenthaler; Silke Johann; Sara Imboden; Nicolas Samartzis; Haiyan Ledermann-Liu; Dimitri Sarlos; Markus Eberhard; Michael D Mueller
Journal:  Ann Surg Oncol       Date:  2022-09-04       Impact factor: 4.339

4.  Technical modifications in the robotic-assisted surgical approach for gynaecologic operations.

Authors:  Frederik Peeters; Zvi Vaknin; Susie Lau; Claire Deland; Sonya Brin; Walter H Gotlieb
Journal:  J Robot Surg       Date:  2010-11-10

5.  Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer.

Authors:  Alessandro Santi; Annette Kuhn; Thomas Gyr; Markus Eberhard; Silke Johann; Andreas R Günthert; Michael D Mueller
Journal:  Surg Endosc       Date:  2009-06-16       Impact factor: 4.584

6.  Total laparoscopic hysterectomy versus total abdominal hysterectomy with bilateral salpingo-oophorectomy for endometrial carcinoma: a randomised controlled trial with 5-year follow-up.

Authors:  Kirsten B Kluivers; Florien A Ten Cate; Marlies Y Bongers; Hans A M Brölmann; Jan C M Hendriks
Journal:  Gynecol Surg       Date:  2011-03-11

7.  Lymphovascular space invasion in robotic surgery for endometrial cancer.

Authors:  Mark R Hopkins; Abby M Richmond; Georgina Cheng; Susan Davidson; Monique A Spillman; Jeanelle Sheeder; Miriam D Post; Saketh R Guntupalli
Journal:  JSLS       Date:  2014 Jul-Sep       Impact factor: 2.172

8.  Intraperitoneal cytology after laparoscopic hysterectomy in patients with endometrial cancer: A retrospective observational study.

Authors:  Tomohito Tanaka; Yoshito Terai; Kazuya Maeda; Keisuke Ashihara; Yuhei Kogata; Hiroshi Maruoka; Shinichi Terada; Takashi Yamada; Masahide Ohmichi
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

9.  Does the Type of Surgical Approach and the Use of Uterine Manipulators Influence the Disease-Free Survival and Recurrence Rates in Early-Stage Endometrial Cancer?

Authors:  Josefa Marcos-Sanmartín; José Antonio López Fernández; José Sánchez-Payá; Óscar Cruz Piñero-Sánchez; María José Román-Sánchez; María Asunción Quijada-Cazorla; María Amparo Candela-Hidalgo; Juan Carlos Martínez-Escoriza
Journal:  Int J Gynecol Cancer       Date:  2016-11       Impact factor: 3.437

10.  Comparative analyses of postoperative complications and prognosis of different surgical procedures in stage II endometrial carcinoma treatment.

Authors:  Hongmei Yin; Ting Gui
Journal:  Onco Targets Ther       Date:  2016-02-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.